Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nocturnal Melatonin Ingestion Ameliorates Short Term Maximal Performances on the Following Day

NCT02876770 is registered in ClinicalTrials.gov with kais as lead sponsor.

NCT NCT02876770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02876770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nocturnal Melatonin Ingestion Ameliorates Short Term Maximal Performances on the Following Day
Lead sponsor
kais
Phase
Phase 1
Overall status
Terminated
Start date
December 31, 2012
Completion date
January 31, 2013
Enrollment
12 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

motor activity